| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000003675 |
| Receipt No. | R000004457 |
| Official scientific title of the study | Impact of functional imaging on the evaluation of treatment effect after neoadjuvant chemoradiation therapy for non-small cell lung cancer |
| Date of disclosure of the study information | 2010/05/31 |
| Last modified on | 2017/02/15 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Impact of functional imaging on the evaluation of treatment effect after neoadjuvant chemoradiation therapy for non-small cell lung cancer | |
| Title of the study (Brief title) | Impact of functional imaging on the evaluation of treatment effect after neoadjuvant chemoradiation therapy for non-small cell lung cancer | |
| Region |
|
|
| Condition | ||||
| Condition | Non-Small Cell Lung Cancer | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To detect an useful index about the treatment effect prediction of neoadjuvant chemoradiation therapy for non-small cell lung cancer by evaluating of changes of functional imaging before and after neoadjuvant chemoradiation therapy and the pathological information obtained after operation. |
| Basic objectives2 | Others |
| Basic objectives -Others | Utility of functional imaging about treatment effect prediction |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Accuracy of treatment effect prediction by functional imaging |
| Key secondary outcomes | Pathological response of preoperative therapy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Undergo PET/CT and plain MRI (including diffusion-weighted image) before and after neoadjuvant chemoradiation therapy. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Histologically confirmed Non-small cell lung cancer.
2.Adequate bone marrow function WBC more than 4000/ul, Platelet count more than 100,000/ul. 3.Adequate liver function. (T.Bil less than 1.5mg/dl) 4.Adequate renal level. (serum creatinin less than 1.5mg/dl, Creatinine clearlance more than 60mg/dl) 5.Adequate pulmonary function (PaO2 more than 70Torr) 6. No other severe complications. Agreement for the protocol by physicians, surgeons and radiologists is essential. 7.Written informed consent to participate in the trial is necessary |
|||
| Key exclusion criteria | 1.Malignant pleuritis or malignant pericarditis.
2.Pleural dissemination. 3.Patients with severe complications. a.Pulmonary fibrosis. b.Severe heart disease.(Uncontrollable angina or myocardial infarction within the past 3 months) c.Uncontrollable Diabetes Mellitus. d.Severe infectious disease e.Other unsuitable patient judged by a physician. 4.Women during pregnancy or lactating. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Yoichi Otomi |
| Organization | University of Tokushima |
| Division name | Department of radiology |
| Address | 2-50-1, Kuramoto-cho, Tokushima |
| TEL | 088-633-9283 |
| otomi.yoichi@tokushima-u.ac.jp | |
| Public contact | |
| Name of contact person | Yoichi Otomi |
| Organization | University of Tokushima |
| Division name | Department of radiology |
| Address | 2-50-1, Kuramoto-cho, Tokushima |
| TEL | 088-633-9283 |
| Homepage URL | |
| otomi.yoichi@tokushima-u.ac.jp | |
| Sponsor | |
| Institute | University of Tokushima |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004457 |